Everett Vokes
University of Chicago · The University of Chicago Medical Center · Study Principal Investigator
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Registry trials as an overall official
15
all conditions, ClinicalTrials.gov
NIH grants tied to them
7
NIH RePORTER
Trial papers
293
PubMed author-name match
Trials
Studies that name Everett Vokes as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 03:48 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT03944915 · De-Escalation Therapy for Human Papillomavirus Negative DiseaseUniversity of Chicago · completed · Human Papilloma Virus, Squamous Cell Carcinoma, Squamous Cell Carcinoma of the Head and Neck · principal investigator
- Ph2NCT03107182 · Chemotherapy and Locoregional Therapy Trial (Surgery or Radiation) for Patients With Head and Neck CancerUniversity of Chicago · completed · HPV-Related Squamous Cell Carcinoma, HNSCC · principal investigator
- Ph2NCT02258659 · Nab-paclitaxel and Carboplatin Followed by Response-Based Local Therapy in Treating Patients With Stage III or IV HPV-Related Oropharyngeal CancerUniversity of Chicago · completed · Human Papilloma Virus Infection, Stage III Squamous Cell Carcinoma of the Oropharynx, Stage IVA Squamous Cell Carcinoma of the Oropharynx · principal investigator
- Ph2NCT01693718 · A Multicenter Study of Intensive Concomitant Chemoradiotherapy With Filgrastim (GCSF) for Patients With Locoregionally Advanced Head and Neck CancerUniversity of Chicago · completed · Head and Neck · principal investigator
- Early Ph1NCT01359267 · Feasibility of Imaging in the Treatment of Patients With Advanced Head and Neck CancerUniversity of Chicago · completed · Head and Neck Cancer · principal investigator
- Ph2NCT01185171 · Trial of Induction Chemotherapy With Carboplatin and Paclitaxel, Followed by Concurrent Chemotherapy/Radiation Therapy With ZD1839 (IRESSA), 5-FU, Hydroxyurea, and Twice-Daily Radiation, Followed by Adjuvant ZD1839 Monotherapy in Patients With Locally Advanced Head & Neck CancerUniversity of Chicago · completed · Head and Neck Cancer · principal investigator
- Ph2NCT01133678 · Study in Locally Advanced Squamous Cell Carcinoma of Head and NeckUniversity of Chicago · terminated · Head and Neck Cancer · principal investigator
- Ph2NCT01133665 · Cetuximab and Lenalidomide in Head and NeckUniversity of Chicago · completed · Squamous Cell Carcinoma · study chair
- Ph1/Ph2NCT00496236 · Radiotherapy, Cetuximab, and Injections of TNFerade™ Biologic for Elderly or Frail Patients With Head and Neck CancerGenVec · completed · Head and Neck Cancer, Head and Neck Neoplasms · principal investigator
- Ph1/Ph2NCT00496535 · A Study of TNFerade™ Biologic With Concomitant Radiotherapy, Fluorouracil, and Hydroxyurea (TNF-FHX) in Patients With Head and Neck CancerGenVec · completed · Head and Neck Cancer, Head and Neck Neoplasms · principal investigator
- Ph1NCT00369551 · Bevacizumab, Paclitaxel, Carboplatin, and Radiation Therapy to the Chest in Treating Patients With Locally Advanced Non-Small Cell Lung CancerNational Cancer Institute (NCI) · terminated · Adenocarcinoma of the Lung, Bronchoalveolar Cell Lung Cancer, Large Cell Lung Cancer · principal investigator
- Ph2NCT00203905 · A Study of Chemoradiotherapy for Intermediate Stage/Selected Stage IV Cancers of the Head and NeckUniversity of Chicago · completed · Head and Neck Cancer · principal investigator
- Ph3NCT00117572 · Docetaxel Based Chemotherapy Plus or Minus Induction Chemotherapy to Decrease Events in Head and Neck Cancer (DeCIDE)University of Chicago · completed · Cancer of the Pharynx, Cancer of the Larynx, Cancer of the Nasal Cavity · principal investigator
- Ph2NCT00015964 · ZD 1839 in Treating Patients With Metastatic or Recurrent Cancer of the Head and NeckUniversity of Chicago · completed · Head and Neck Cancer · study chair
- Ph1NCT00023959 · Bevacizumab, Fluorouracil, and Hydroxyurea Plus Radiation Therapy in Treating Patients With Advanced Head and Neck CancerNational Cancer Institute (NCI) · completed · Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Adenoid Cystic Carcinoma of the Oral Cavity, Recurrent Basal Cell Carcinoma of the Lip · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 03:48 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- PROGRAM 4 (CLINICAL AND EXPERIMENTAL THERAPEUTICS)P30CA014599 · NCI · UNIVERSITY OF CHICAGO · fiscal years 1992 to 2012 · $38,634 awarded in 2012Grant number is on one of their registry trials
- Early Therapeutics Development with Phase II EmphasisN01CM62201- · NCI · UNIVERSITY OF CHICAGO · fiscal years 2007 to 2010 · $207,512 awarded in 2010Grant number is on one of their registry trials
- EARLY THERAPEUTICS DEVELOPMENT WITH PHASE II EMPHASIS-261622001N01CM622001 · NCI · THE UNIVERSITY OF CHICAGO · fiscal years 2006Same name and institution; not confirmed by an ID
- EARLY THERAPEUTICS DEVELOPMENT WITH PHASE 2 EMPHASIS-261017102N01CA017102 · NCI · THE UNIVERSITY OF CHICAGO · fiscal years 2004 to 2005Same name and institution; not confirmed by an ID
- CARCINOGENESIS AND NOVEL THERAPEUTICS IN ORAL CANCERP50DE011921 · NIDCR · UNIVERSITY OF CHICAGO · fiscal years 1996 to 2001 · $4,553 awarded in 2001Same name and institution; not confirmed by an ID
- COOPERATIVE STUDYU01CA063187 · NCI · UNIVERSITY OF CHICAGO · fiscal years 1994 to 2000 · $320,533 awarded in 2000Same name and institution; not confirmed by an ID
- INTRAVENOUS ADMINISTRATION OF 14C LOSOXANTRONE (DUP941) FOR SOLID TUMORSM01RR000055 · NCRR · UNIVERSITY OF CHICAGO · fiscal years 1997 · $37,151 awarded in 1997Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 03:48 UTC. The ranking covers the 200 most relevant of 293 PubMed records, and a shared surname and initials can bring in a namesake. All 293 on PubMed
- 7,991 citationsRCR 252.7
- 7,058 citationsRCR 224.4
- Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck.N Engl J Med · 20164,165 citationsRCR 143.4
- Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer.N Engl J Med · 20222,541 citationsRCR 184.1
- 1,178 citationsRCR 24.5
- 1,120 citationsRCR 146.5
- 793 citationsRCR 17.9
- 732 citationsRCR 21.9
- 650 citationsRCR 13.7
- 647 citationsRCR 23.1